Episode 517: PREMIUM – A podcast that hopefully won’t leave you breathless
Episode 517: PREMIUM – A podcast that hopefully won’t leave you breathless
In episode 517, Mike and James talk PREMIUMLY (not a word but it should be) about two new trials that looked at using fixed dose combinations of salbutamol/albuterol and a steroid on a PRN basis in patients with moderate to severe asthma. It seems to have an effect and it may make asthma treatment simpler, but it may also increase the costs when it comes to inhalers.
Show Notes
1) Albuterol–Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma
N Engl J Med 2022;386:2071-83.DOI: 10.1056/NEJMoa22031632
2) Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma
N Engl J Med 2022;386:1505-18.DOI: 10.1056/NEJMoa2118813
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
